Viewing nowCombinationBesilsartan Q Tablets 5/50/10 mg (Amlodipine, Losartan, Rosuvastatin)
Amlodipine Besylate 6.94mg · Losartan Potassium 50mg +1 more
Tablet · Prescription medication · Combination
Huons Co., Ltd.

MFDS item code 202502494 · Approved 2025.09.19
Treatment of hypertension and dyslipidemia; inhibition of arteriosclerosis progression and reduction of cardiovascular disease risk
This medication effectively controls hypertension with the combination of Amlodipine and Losartan, and is used as initial treatment for patients with essential hypertension or stage 2 hypertension where blood pressure is not adequately controlled with monotherapy. The Rosuvastatin component helps reduce blood cholesterol levels in patients with hypercholesterolemia and hyperlipidemia who are not controlled adequately by diet, thereby slowing the progression of atherosclerosis and reducing cardiovascular disease risk. It helps decrease the risk of problems that may occur after stroke, myocardial infarction, and arterial revascularization. Therefore, this medication can be used safely and effectively in patients with both hypertension and dyslipidemia.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/losartan combination and rosuvastatin. ○ Amlodipine/losartan combination The recommended dose of the amlodipine/losartan combination in adults is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). Before administering the amlodipine/losartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not adequately controlled with monotherapy using the individual components, a direct switch to the amlodipine/losartan combination may be considered, as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Before administering the amlodipine/losartan combination as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment goal with the combination compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ∘ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50mL/min); however, use of the amlodipine/losartan combination is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ∘ Patients with reduced effective intravascular blood volume: Use of the amlodipine/losartan combination is not recommended in a small number of patients with reduced effective intravascular blood volume (e.g., patients receiving treatment with high-dose diuretics). (See 1. Warnings under Precautions for Use.) ∘ Patients with hepatic impairment: Use of the amlodipine/losartan combination is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ∘ Older adults: In older adults aged 75 years or older, an initial losartan dose of 25 mg once daily is recommended; therefore, use of the amlodipine/losartan combination as initial therapy is not recommended. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin, and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose in adults is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased to a maximum of 20 mg once daily. 2. Older adults: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients. For patients taking the amlodipine/losartan combination concomitantly with rosuvastatin, they may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience of administration.
This medication can pose serious risks to the fetus and newborn during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. When administered for the first time to patients with low blood volume, hypotension may occur, so careful monitoring of the condition is necessary. Patients with allergies to any of the ingredients of this medication, certain genetic disorders, or severely impaired liver or kidney function should not take it. Elderly patients and those with hypotension, hyperkalemia, or liver function impairment should use it with caution. Patients with heart or kidney disease should also take it with care. Muscle pain or myopathy may occur, and, rarely, severe muscle breakdown, so if any muscle-related symptoms arise, consult a doctor immediately. This medication can affect liver function, so it's advisable to have liver function tests done regularly before and during use. There may be drug interactions, so if you are taking other medications, inform your doctor or pharmacist. Particularly, caution is advised when used with potassium-sparing diuretics or potassium supplements as it may increase the risk of hyperkalemia. Patients with a history of alcohol use or liver disease should be extra cautious when taking this medication, and dosage adjustments may be necessary. Dizziness or drowsiness may occur during the use of this medication, so caution is advised when driving or operating machinery. If any unusual symptoms occur during medication, it's important to consult healthcare professionals for appropriate action.
Craniosynostosis, anuria, hypotension, renal failure, upper respiratory infection, dizziness, dyspepsia, lower gastrointestinal bleeding, positional dizziness, pre-syncope, rhabdomyolysis, pancreatic adenocarcinoma, dizziness, headache, drowsiness, cerebral infarction, weakness, chest discomfort, chest pain, early satiety, peripheral edema, dependent edema, abdominal discomfort, nausea, gastroesophageal reflux disease, constipation, pruritus, urticaria, palpitations, flushing, orthostatic hypotension, facial flushing, dyspnea, cough, conjunctival injection, frequent urination, angioedema, diabetes, constipation, nausea, abdominal pain, pancreatitis, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, drug-induced lichen planus-like rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, acute renal failure, oliguria, increased serum creatinine, leukopenia, thrombocytopenia, hypotension, vasculitis, tension hypertension, sensory loss, paresthesia, peripheral neuropathy, syncope, taste disturbance, tremor, extrapyramidal disorder, erectile dysfunction, gynecomastia, change in bowel habits, dry mouth, dyspepsia, gingival hyperplasia, pancreatitis, vomiting, hyperglycemia, arthralgia, lower back pain, muscle cramps, myalgia, insomnia, mood changes, cough, dyspnea, rhinitis, alopecia, hyperhidrosis, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbances, erectile dysfunction, nocturia, increased urination frequency, urination disorders, hepatitis, jaundice, elevated liver enzymes, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, chest pain, hypotension, sinoatrial block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, erythematous rash, maculopapular rash, heaviness, warmth sensation, impaired glucose tolerance, weakness, facial edema, fever, orthostatic effects, syncope, angina, second-degree atrioventricular block, cerebrovascular accident, hypotension, myocardial infarction, atrial fibrillation, palpitations, bradycardia, tachycardia, ventricular tachycardia, ventricular fibrillation, anorexia, toothache, dry mouth, flatulence, gastritis, vomiting, anemia, gout, upper limb pain, hip pain, joint swelling, knee pain, myasthenia, anxiety, anxiety disorder, ataxia, confusion, depression, nightmares, sensory reduction, decreased libido, memory impairment, migraine, neuroexcitability, panic disorder, sleep disorders, hypersomnolence, tremor, dizziness, bronchitis, pharyngeal discomfort, nasal bleeding, rhinitis, respiratory congestion, chest discomfort, alopecia, dermatitis, dry skin, petechial hemorrhage, erythema, flushing, photosensitivity, pruritus, rash, sweating, urticaria, blurred vision, eye burning sensation, conjunctivitis, taste disturbance, tinnitus, vision loss, nocturia, frequent urination, urethral infection, angioedema, vasculitis, anaphylaxis-like syndrome, liver dysfunction, hepatitis, intestinal vascular edema, malaise, anemia, thrombocytopenia, myalgia, weakness, elevated creatine kinase, rhabdomyolysis, taste disturbance, dry cough, erythematous dermatitis, hyperkalemia, hyponatremia, ALT elevation, acute hepatitis, fulminant hepatitis, renal failure, ventricular premature contraction, atrial fibrillation, hypoglycemia, weakness, hunger, cold sweat, hand tremors, decreased concentration, convulsions, altered consciousness
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container protected from air and moisture, and kept at room temperature between 1 to 30 degrees Celsius. This storage helps maintain the effectiveness of the medication and allows for safe use.
Pale yellow oval film-coated tablet
PTP - 30 tablets/box [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Losartan Potassium 50mg +1 more
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Losartan Potassium 100mg +1 more
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.